6. Water Treatment 71 6
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Drinking Water Treatment Systems
Drinking Water Facts….. Drinking Water Treatment Systems By: Barbara Daniels and Nancy Mesner Revised December 2010 If your home water comes from a public water supply, it has been tested and meets EPA standards for drinking water. If you use a private well, however, you are responsible for assuring that the water is safe to drink. This means that you should periodically have your water tested, make sure your well is in proper condition without faulty well caps or seals, and identify and remove potential sources of con- tamination to your well such as leaking septic systems or surface contamination. With a private well, you are also responsible for any treatment your water may need if it contains harm- ful pollutants or contaminants that affect the taste, odor, corrosiveness or hardness of the water. This fact sheet discusses different types of water treatment systems available to homeowners. Addressing the source of the problem is often less costly in the long run than installing and maintaining a water system. For more information on identifying pollutant sources, problems with your well, or help in testing your well water, see the references at the end of this fact sheet. There are many types of water treatment systems available. No one type of treatment can address every water quality problem, so make sure you purchase the type of equipment that can effectively treat your particular water quality issue. The table below can help direct you to the right solution for your prob- lem. Drinking Water Facts….. What type of water treatment is needed? The table below lists common water contamination problems. -
Total Organic Carbon (TOC) Guidance Manual
September 2002 RG-379 (Revised) Total Organic Carbon (TOC) Guidance Manual Water Supply Division printed on recycled paper TEXAS COMMISSION ON ENVIRONMENTAL QUALITY Total Organic Carbon (TOC) Guidance Manual Prepared by Water Supply Division RG-379 (Revised) September 2002 Robert J. Huston, Chairman R. B. “Ralph” Marquez, Commissioner Kathleen Hartnett White, Commissioner Jeffrey A. Saitas, Executive Director Authorization to use or reproduce any original material contained in this publication—that is, not obtained from other sources—is freely granted. The commission would appreciate acknowledgment. Copies of this publication are available for public use through the Texas State Library, other state depository libraries, and the TCEQ Library, in compli- ance with state depository law. For more information on TCEQ publications call 512/239-0028 or visit our Web site at: www.tceq.state.tx.us/publications Published and distributed by the Texas Commission on Environmental Quality PO Box 13087 Austin TX 78711-3087 The Texas Commission on Environmental Quality was formerly called the Texas Natural Resource Conservation Commission. The TCEQ is an equal opportunity/affirmative action employer. The agency does not allow discrimination on the basis of race, color, religion, national origin, sex, disability, age, sexual orientation or veteran status. In compliance with the Americans with Disabilities Act, this document may be requested in alternate formats by contacting the TCEQ at 512/239-0028, Fax 239-4488, or 1-800-RELAY-TX (TDD), or by writing -
History of the Chlor-Alkali Industry
2 History of the Chlor-Alkali Industry During the last half of the 19th century, chlorine, used almost exclusively in the textile and paper industry, was made [1] by reacting manganese dioxide with hydrochloric acid 100–110◦C MnO2 + 4HCl −−−−−−→ MnCl2 + Cl2 + 2H2O (1) Recycling of manganese improved the overall process economics, and the process became known as the Weldon process [2]. In the 1860s, the Deacon process, which generated chlorine by direct catalytic oxidation of hydrochloric acid with air according to Eq. (2) was developed [3]. ◦ 450–460 C;CuCl2 cat. 4HCl + O2(air) −−−−−−−−−−−−−−→ 2Cl2 + 2H2O(2) The HCl required for reactions (1) and (2) was available from the manufacture of soda ash by the LeBlanc process [4,5]. H2SO4 + 2NaCl → Na2SO4 + 2HCl (3) Na2SO4 + CaCO3 + 2C → Na2CO3 + CaS + 2CO2 (4) Utilization of HCl from reaction (3) eliminated the major water and air pollution problems of the LeBlanc process and allowed the generation of chlorine. By 1900, the Weldon and Deacon processes generated enough chlorine for the production of about 150,000 tons per year of bleaching powder in England alone [6]. An important discovery during this period was the fact that steel is immune to attack by dry chlorine [7]. This permitted the first commercial production and distribu- tion of dry liquid chlorine by Badische Anilin-und-Soda Fabrik (BASF) of Germany in 1888 [8,9]. This technology, using H2SO4 for drying followed by compression of the gas and condensation by cooling, is much the same as is currently practiced. 17 “chap02” — 2005/5/2 — 09Brie:49 — page 17 — #1 18 CHAPTER 2 In the latter part of the 19th century, the Solvay process for caustic soda began to replace the LeBlanc process. -
Integrated Pollution Prevention and Control (IPPC) Reference Document on Best Available Techniques in the Chlor-Alkali Manufacturing Industry December 2001
EUROPEAN COMMISSION Integrated Pollution Prevention and Control (IPPC) Reference Document on Best Available Techniques in the Chlor-Alkali Manufacturing industry December 2001 Executive summary EXECUTIVE SUMMARY This reference document on best available techniques in the chlor-alkali industry reflects an information exchange carried out according to Article 16(2) of Council Directive 96/61/EC. The document has to be seen in the light of the preface which describes the objectives of the document and its use. The chlor-alkali industry The chlor-alkali industry is the industry that produces chlorine (Cl2) and alkali, sodium hydroxide (NaOH) or potassium hydroxide (KOH), by electrolysis of a salt solution. The main technologies applied for chlor-alkali production are mercury, diaphragm and membrane cell electrolysis, mainly using sodium chloride (NaCl) as feed or to a lesser extent using potassium chloride (KCl) for the production of potassium hydroxide. The diaphragm cell process (Griesheim cell, 1885) and the mercury cell process (Castner- Kellner cell, 1892) were both introduced in the late 1800s. The membrane cell process was developed much more recently (1970). Each of these processes represents a different method of keeping the chlorine produced at the anode separate from the caustic soda and hydrogen produced, directly or indirectly, at the cathode. Currently, 95% of world chlorine production is obtained by the chlor-alkali process. The geographic distribution of chlor-alkali processes world-wide differs appreciably (production capacity of chlorine): - western Europe, predominance of mercury cell process (June 2000): 55% - United States, predominance of diaphragm cell process: 75% - Japan, predominance of membrane cell process: >90% The remaining chlorine production capacity in western Europe consists of (June 2000) diaphragm cell process 22%, membrane cell process 20% and other processes 3%. -
Environmental Protection Agency
Friday, December 19, 2003 Part II Environmental Protection Agency 40 CFR Part 63 National Emission Standards for Hazardous Air Pollutants: Mercury Emissions from Mercury Cell Chlor-Alkali Plants; Final Rule VerDate jul<14>2003 15:14 Dec 18, 2003 Jkt 203001 PO 00000 Frm 00001 Fmt 4717 Sfmt 4717 E:\FR\FM\19DER2.SGM 19DER2 70904 Federal Register / Vol. 68, No. 244 / Friday, December 19, 2003 / Rules and Regulations ENVIRONMENTAL PROTECTION types of sources (usually in the Information or other information whose AGENCY elemental or inorganic forms) transports disclosure is restricted by statute. through the atmosphere and eventually The official public docket is the 40 CFR Part 63 deposits onto land or water bodies. collection of materials that is available [OAR–2002–0017; FRL–7551–5] When mercury is deposited to surface for public viewing. The EPA Docket waters, natural processes (bacterial) can RIN 2060–AE85 Center Public Reading Room is open transform some of the mercury into from 8:30 a.m. to 4:30 p.m., Monday methylmercury that accumulates in fish. through Friday, excluding legal National Emission Standards for Ingestion is the primary exposure route Hazardous Air Pollutants: Mercury holidays. The telephone number for the of interest for methylmercury. The Reading Room is (202) 566–1744, and Emissions From Mercury Cell Chlor- health effect of greatest concern due to Alkali Plants the telephone number for the Air Docket methylmercury is neurotoxicity, is (202) 566–1742. AGENCY: Environmental Protection particularly with respect to fetuses and Agency (EPA). young children. Electronic Docket Access. You may access the final rule electronically ACTION: Final rule. -
Consumer Confidence Report for 2012
City of Oregon Water Treatment Plant 2012 Water Quality Report The Oregon Water Treatment Plant’s drinking water continues to surpass all federal and state drinking-water standards. This is the fifthteenth annual report on the quality of water delivered by the City of Oregon. It meets the federal Safe Drinking Water Act (SDWA) requirement for “Consumer Confidence Reports”. Safe water is vital to our community. We have a current, unconditioned license to operate our water system. Please read this report carefully and, if you have any questions, call the numbers listed below. Serving You With EXCELLENT Water Quality and Supply Is Our GOAL If we can further assist in answering your questions regarding the water plant or any other water treatment issues, please call Doug Wagner, Superintendent of Water Treatment at 419-698-7123, between the hours of 7:30 AM and 4:00 PM weekdays or on the web at: www.oregonohio.org and follow the links to “The Departments”, then to “The Utilities” and click on “The Water Plant” for our web page and E-mail link. All contract or monetary decisions concerning the water plant are made at city council meetings held the second and fourth Mondays at 8:00 PM in Oregon Council Chambers. Meeting agendas are posted in the municipal building main hallway by the main door and also by following the link to “The City Council” on the city’s web site; www.oregonohio.org This buoy marked the intake structure in Lake Erie when the Plant was built in 1962 and is now on display at the Water Plant. -
19. Water Treatment Plants. the Introduction (Chapter 1) for These
Chapter 4 – Specifications Designs 19. Water Treatment Plants 19. Water Treatment Plants. The Introduction (Chapter 1) for these design data collection guidelines contains additional information concerning: preparing a design data collection request, design data collection requirements, and coordinating the design data collection and submittal. The following is a list of possible data required for specifications design of water treatment facilities. The size and complexity of the process system and structures should govern the amount and detail of the design data required. A. General Map Showing: (1) A key map locating the general map area within the State. (2) The plant site and other applicable construction areas. (3) Existing towns, highways, roads, railroads, public utilities (electric power, telephone lines, pipelines, etc.), streams, stream-gauging stations, canals, drainage channels. (4) Existing or potential areas or features having a bearing on the design, construction, operation, or management of the project feature such as: recreation areas; fish and wildlife areas; building areas; and areas of archeological, historical, and mining or paleontological interest. The locations of these features should bear the parenthetical reference to the agency most concerned: for example Reclamation. (5) County lines, township lines, range lines, and section lines. (6) Locations of construction access roads, permanent roads, and sites for required construction facilities. (7) Sources of natural construction materials and disposal areas for waste material, including the extent of mitigation required. (a) Location of disposal areas for debris, sediment, sludge, and spent chemicals from cleaning or storage solutions. (8) Water sources to be treated such as surface water or underground water. (9) Location of potential waste areas (i.e., channels). -
Optimization of Electrolysis Parameters for Green Sanitation Chemicals Production Using Response Surface Methodology
processes Article Optimization of Electrolysis Parameters for Green Sanitation Chemicals Production Using Response Surface Methodology Nurul Izzah Khalid 1 , Nurul Shaqirah Sulaiman 1 , Norashikin Ab Aziz 1,2,* , Farah Saleena Taip 1, Shafreeza Sobri 3 and Nor-Khaizura Mahmud Ab Rashid 4 1 Department of Process and Food Engineering, Faculty of Engineering, Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia; [email protected] (N.I.K.); [email protected] (N.S.S.); [email protected] (F.S.T.) 2 Halal Products Research Institute, University Putra Malaysia, UPM Serdang 43300, Selangor, Malaysia 3 Department of Chemical and Environmental Engineering, Faculty of Engineering, Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia; [email protected] 4 Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia; [email protected] * Correspondence: [email protected]; Tel.: +603-9769-4302 Received: 22 May 2020; Accepted: 10 June 2020; Published: 6 July 2020 Abstract: Electrolyzed water (EW) shows great potential as a green and economical sanitation solution for the food industry. However, only limited studies have investigated the optimum electrolysis parameters and the bactericidal effect of acidic electrolyzed water (AcEW) and alkaline electrolyzed water (AlEW). Here, the Box–Behnken experimental design was used to identify the optimum parameters. The tests were conducted with different types of electrodes, electrical voltages, electrolysis times, and NaCl concentrations. There were no obvious differences observed in the physico-chemical properties of EW when different electrodes were used. However, stainless steel was chosen as it meets most of the selection criteria. -
Recommended Standards for Water Works 2007 Edition
Recommended Standards for Water Works 2007 Edition Policies for the Review and Approval of Plans and Specifications for Public Water Supplies A Report of the Water Supply Committee of the Great Lakes--Upper Mississippi River Board of State and Provincial Public Health and Environmental Managers MEMBER STATES AND PROVINCE Illinois Indiana Iowa Michigan Minnesota Missouri New York Ohio Ontario Pennsylvania Wisconsin Published by: Health Research Inc., Health Education Services Division, P.O. Box 7126, Albany, NY 12224 (518)439-7286 www.hes.org Copyright © 2007 by the Great Lakes - Upper Mississippi River Board of State and Provincial Public Health and Environmental Managers This book, or portions thereof, may be reproduced without permission from the author if proper credit is given. TABLE OF CONTENTS FOREWORD POLICY STATEMENT ON PRE-ENGINEERED WATER TREATMENT PLANTS POLICY STATEMENT ON AUTOMATED/UNATTENDED OPERATION OF SURFACE WATER TREATMENT PLANTS POLICY STATEMENT ON BAG AND CARTRIDGE FILTERS FOR PUBLIC WATER SUPPLIES POLICY STATEMENT ON ULTRA VIOLET LIGHT FOR TREATMENT OF PUBLIC WATER SUPPLIES POLICY STATEMENT ON INFRASTRUCTURE SECURITY FOR PUBLIC WATER SUPPLIES POLICY STATEMENT ON ARSENIC REMOVAL INTERIM STANDARD - NITRATE REMOVAL USING SULFATE SELECTIVE ANION EXCHANGE RESIN INTERIM STANDARD - USE OF CHLORAMINE DISINFECTANT FOR PUBLIC WATER SUPPLIES INTERIM STANDARD ON MEMBRANE TECHNOLOGIES FOR PUBLIC WATER SUPPLIES PART 1 - SUBMISSION OF PLANS 1.0 GENERAL 1.1 ENGINEER’S REPORT 1.1.1 General Information 1.1.2 Extent of water works -
)&F1y3x PHARMACEUTICAL APPENDIX to THE
)&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE -
NINDS Custom Collection II
ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC -
A Screening-Based Approach to Circumvent Tumor Microenvironment
JBXXXX10.1177/1087057113501081Journal of Biomolecular ScreeningSingh et al. 501081research-article2013 Original Research Journal of Biomolecular Screening 2014, Vol 19(1) 158 –167 A Screening-Based Approach to © 2013 Society for Laboratory Automation and Screening DOI: 10.1177/1087057113501081 Circumvent Tumor Microenvironment- jbx.sagepub.com Driven Intrinsic Resistance to BCR-ABL+ Inhibitors in Ph+ Acute Lymphoblastic Leukemia Harpreet Singh1,2, Anang A. Shelat3, Amandeep Singh4, Nidal Boulos1, Richard T. Williams1,2*, and R. Kiplin Guy2,3 Abstract Signaling by the BCR-ABL fusion kinase drives Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) and chronic myelogenous leukemia (CML). Despite their clinical activity in many patients with CML, the BCR-ABL kinase inhibitors (BCR-ABL-KIs) imatinib, dasatinib, and nilotinib provide only transient leukemia reduction in patients with Ph+ ALL. While host-derived growth factors in the leukemia microenvironment have been invoked to explain this drug resistance, their relative contribution remains uncertain. Using genetically defined murine Ph+ ALL cells, we identified interleukin 7 (IL-7) as the dominant host factor that attenuates response to BCR-ABL-KIs. To identify potential combination drugs that could overcome this IL-7–dependent BCR-ABL-KI–resistant phenotype, we screened a small-molecule library including Food and Drug Administration–approved drugs. Among the validated hits, the well-tolerated antimalarial drug dihydroartemisinin (DHA) displayed potent activity in vitro and modest in vivo monotherapy activity against engineered murine BCR-ABL-KI–resistant Ph+ ALL. Strikingly, cotreatment with DHA and dasatinib in vivo strongly reduced primary leukemia burden and improved long-term survival in a murine model that faithfully captures the BCR-ABL-KI–resistant phenotype of human Ph+ ALL.